These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 37863464)

  • 1. Comparison of estrogenic components used for hormonal contraception.
    Stanczyk FZ; Winer SA; Foidart JM; Archer DF
    Contraception; 2024 Feb; 130():110310. PubMed ID: 37863464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the effect of a new oral contraceptive containing estetrol and drospirenone on hemostasis parameters.
    Douxfils J; Klipping C; Duijkers I; Kinet V; Mawet M; Maillard C; Jost M; Rosing J; Foidart JM
    Contraception; 2020 Dec; 102(6):396-402. PubMed ID: 32956694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oestrogens in oral contraception: considerations for tailoring prescription to women's needs.
    Fruzzetti F; Fidecicchi T; Gambacciani M
    Eur J Contracept Reprod Health Care; 2024 Jun; 29(3):93-102. PubMed ID: 38683756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of an oral contraceptive containing estetrol and drospirenone on ovarian function.
    Duijkers I; Klipping C; Kinet V; Jost M; Bastidas A; Foidart JM
    Contraception; 2021 Jun; 103(6):386-393. PubMed ID: 33689786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic effects of contraceptive steroids.
    Sitruk-Ware R; Nath A
    Rev Endocr Metab Disord; 2011 Jun; 12(2):63-75. PubMed ID: 21538049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unique effects on hepatic function, lipid metabolism, bone and growth endocrine parameters of estetrol in combined oral contraceptives.
    Mawet M; Maillard C; Klipping C; Zimmerman Y; Foidart JM; Coelingh Bennink HJ
    Eur J Contracept Reprod Health Care; 2015; 20(6):463-75. PubMed ID: 26212489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endocrine and metabolic effects of an oral contraceptive containing estetrol and drospirenone.
    Klipping C; Duijkers I; Mawet M; Maillard C; Bastidas A; Jost M; Foidart JM
    Contraception; 2021 Apr; 103(4):213-221. PubMed ID: 33428907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ethinylestradiol in combined hormonal contraceptive has a broader effect on serum proteome compared with estradiol valerate: a randomized controlled trial.
    Kangasniemi MH; Arffman RK; Joenväärä S; Haverinen A; Luiro K; Tohmola T; Renkonen R; Heikinheimo O; Tapanainen JS; Piltonen TT
    Hum Reprod; 2023 Jan; 38(1):89-102. PubMed ID: 36416543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estetrol: A New Choice for Contraception.
    Fruzzetti F; Fidecicchi T; Montt Guevara MM; Simoncini T
    J Clin Med; 2021 Nov; 10(23):. PubMed ID: 34884326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Combined Hormonal Contraception - Which Pill for Which Patient?].
    Quaas P
    Praxis (Bern 1994); 2023; 112(4):205-210. PubMed ID: 36919319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Venous Thromboembolic Risk of Estradiol Valerate-Dienogest Compared with Ethinyl Estradiol-Levonorgestrel Combined Oral Contraceptives.
    Bauerfeind A; von Stockum S; Boehnke T; Heinemann K
    Obstet Gynecol; 2024 Mar; 143(3):431-434. PubMed ID: 38227942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemostatic and metabolic impact of estradiol pills and drospirenone-containing ethinylestradiol pills vs. levonorgestrel-containing ethinylestradiol pills: A literature review.
    Lete I; Chabbert-Buffet N; Jamin C; Lello S; Lobo P; Nappi RE; Pintiaux A
    Eur J Contracept Reprod Health Care; 2015; 20(5):329-43. PubMed ID: 26007631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drospirenone and estetrol: evaluation of a newly approved novel oral contraceptive.
    Nelson AL
    Expert Opin Pharmacother; 2023; 24(16):1757-1764. PubMed ID: 37691580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of ovulation by administration of estetrol in combination with drospirenone or levonorgestrel: Results of a phase II dose-finding pilot study.
    Duijkers IJ; Klipping C; Zimmerman Y; Appels N; Jost M; Maillard C; Mawet M; Foidart JM; Coelingh Bennink HJ
    Eur J Contracept Reprod Health Care; 2015; 20(6):476-89. PubMed ID: 26394847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel estetrol-containing combined oral contraceptive: European expert panel review.
    Gemzell-Danielsson K; Cagnacci A; Chabbert-Buffet N; Douxfils J; Foidart JM; Kubba A; Lete Lasa LI; Mansour D; Neulen J; Neves J; Palma F; Römer T; Spaczyński R; Tóth V
    Eur J Contracept Reprod Health Care; 2022 Oct; 27(5):373-383. PubMed ID: 35862627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined oral contraceptive with estetrol plus drospirenone: from pharmacokinetics to clinical applications.
    Battipaglia C; Feliciello L; Genazzani AD; Facchinetti F; Grandi G
    Expert Opin Drug Metab Toxicol; 2023 Dec; 19(12):871-879. PubMed ID: 37942662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel estetrol-containing combined oral contraceptive: European expert panel review.
    Gemzell-Danielsson Kristina; Cagnacci Angelo; Chabbert-Buffet Nathalie; Douxfils Jonathan; Foidart Jean-Michel; Kubba Ali; Lasa Luis Ignacio Lete; Mansour Diana; Neulen Joseph; Neves Jaoquim; Palma Fátima; Römer Thomas; Ski Robert Spaczy; Tóth Vera
    Ceska Gynekol; 2022; 87(6):440-452. PubMed ID: 36543594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined oral contraceptives containing estradiol valerate vs ethinylestradiol on coagulation: A randomized clinical trial.
    Haverinen AH; Luiro KM; Szanto T; Kangasniemi MH; Hiltunen L; Sainio S; Piltonen TT; Lassila R; Tapanainen JS; Heikinheimo O
    Acta Obstet Gynecol Scand; 2022 Oct; 101(10):1102-1111. PubMed ID: 35909329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estetrol (E4): the new estrogenic component of combined oral contraceptives.
    Grandi G; Del Savio MC; Lopes da Silva-Filho A; Facchinetti F
    Expert Rev Clin Pharmacol; 2020 Apr; 13(4):327-330. PubMed ID: 32238069
    [No Abstract]   [Full Text] [Related]  

  • 20. Maintaining physiological testosterone levels by adding dehydroepiandrosterone to combined oral contraceptives: I. Endocrine effects.
    Coelingh Bennink HJT; Zimmerman Y; Laan E; Termeer HMM; Appels N; Albert A; Fauser BCJM; Thijssen JHH; van Lunsen RHW
    Contraception; 2017 Nov; 96(5):322-329. PubMed ID: 27393080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.